Lost your password?

Grizzle had the pleasure of sitting down with the CEO of MindMed – JR Rahn.

Terry Chong leads an in-depth and insightful interview with JR, Terry is a veteran pharmaceutical / biotech investor and a partner at Grizzle Ventures.

JR provides a great primer about the evolution of psychedelic research and mental health and how MindMed is pioneering treatments in the emerging medical applications.

 

About Author

Thomas George

Thomas has over 17 years of global institutional investment management experience. At TD Asset Management he was Director of Global Resources and lead Portfolio Manager for over $1 billion of global equities (resource and sustainability funds). Thomas is a CFA charterholder and has been featured on Fox Business, CNBC, Bloomberg, CTV, CBC and the National Post.

See author's posts

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.